Zichen Qiao , Yong Tang , Aobo Shang , You Tao , Bryan G. Fry
{"title":"中国大陆首次记录的卵蝰(山pitvipers)中毒病例:云南省两例患者出现严重凝血功能障碍和抗蛇毒血清反应变化。","authors":"Zichen Qiao , Yong Tang , Aobo Shang , You Tao , Bryan G. Fry","doi":"10.1016/j.toxicon.2025.108583","DOIUrl":null,"url":null,"abstract":"<div><div>Envenomations by <em>Ovophis</em> spp. (mountain pitvipers) are clinically significant yet underreported, especially in mainland China where no confirmed cases have been documented. Here we report two cases of <em>Ovophis</em> envenoming from Yunnan Province that resulted in severe coagulopathy marked by hypofibrinogenemia and elevated D-dimer and FDP levels. In Case 1, a 51-year-old woman bitten by a confirmed <em>O. makazayazaya</em> developed moderate hypofibrinogenemia, which resolved following combined treatment with <em>Deinagkistrodon acutus</em> and <em>Gloydius brevicaudus</em> monovalent antivenoms. In Case 2, a 37-year-old woman bitten by an unidentifiable <em>Ovophis</em> species experienced complete depletion of fibrinogen and prolonged coagulopathy despite treatment with four vials of <em>G. brevicaudus</em> antivenom. These cases highlight the potent coagulotoxic effects of <em>Ovophis</em> venom. Clinical differences between two cases suggest that venom variation and differential antivenom efficacy may influence outcomes. Our findings underscore the need for further research into <em>Ovophis</em> venom composition, cross-neutralization by available antivenoms, and improved species-level identification in clinical settings.</div></div>","PeriodicalId":23289,"journal":{"name":"Toxicon","volume":"267 ","pages":"Article 108583"},"PeriodicalIF":2.4000,"publicationDate":"2025-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"First documented cases of envenomations in mainland China by Ovophis species (mountain pitvipers): Severe coagulopathy and variable antivenom response in two patients from Yunnan Province\",\"authors\":\"Zichen Qiao , Yong Tang , Aobo Shang , You Tao , Bryan G. Fry\",\"doi\":\"10.1016/j.toxicon.2025.108583\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Envenomations by <em>Ovophis</em> spp. (mountain pitvipers) are clinically significant yet underreported, especially in mainland China where no confirmed cases have been documented. Here we report two cases of <em>Ovophis</em> envenoming from Yunnan Province that resulted in severe coagulopathy marked by hypofibrinogenemia and elevated D-dimer and FDP levels. In Case 1, a 51-year-old woman bitten by a confirmed <em>O. makazayazaya</em> developed moderate hypofibrinogenemia, which resolved following combined treatment with <em>Deinagkistrodon acutus</em> and <em>Gloydius brevicaudus</em> monovalent antivenoms. In Case 2, a 37-year-old woman bitten by an unidentifiable <em>Ovophis</em> species experienced complete depletion of fibrinogen and prolonged coagulopathy despite treatment with four vials of <em>G. brevicaudus</em> antivenom. These cases highlight the potent coagulotoxic effects of <em>Ovophis</em> venom. Clinical differences between two cases suggest that venom variation and differential antivenom efficacy may influence outcomes. Our findings underscore the need for further research into <em>Ovophis</em> venom composition, cross-neutralization by available antivenoms, and improved species-level identification in clinical settings.</div></div>\",\"PeriodicalId\":23289,\"journal\":{\"name\":\"Toxicon\",\"volume\":\"267 \",\"pages\":\"Article 108583\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2025-09-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Toxicon\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0041010125003587\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Toxicon","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0041010125003587","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
First documented cases of envenomations in mainland China by Ovophis species (mountain pitvipers): Severe coagulopathy and variable antivenom response in two patients from Yunnan Province
Envenomations by Ovophis spp. (mountain pitvipers) are clinically significant yet underreported, especially in mainland China where no confirmed cases have been documented. Here we report two cases of Ovophis envenoming from Yunnan Province that resulted in severe coagulopathy marked by hypofibrinogenemia and elevated D-dimer and FDP levels. In Case 1, a 51-year-old woman bitten by a confirmed O. makazayazaya developed moderate hypofibrinogenemia, which resolved following combined treatment with Deinagkistrodon acutus and Gloydius brevicaudus monovalent antivenoms. In Case 2, a 37-year-old woman bitten by an unidentifiable Ovophis species experienced complete depletion of fibrinogen and prolonged coagulopathy despite treatment with four vials of G. brevicaudus antivenom. These cases highlight the potent coagulotoxic effects of Ovophis venom. Clinical differences between two cases suggest that venom variation and differential antivenom efficacy may influence outcomes. Our findings underscore the need for further research into Ovophis venom composition, cross-neutralization by available antivenoms, and improved species-level identification in clinical settings.
期刊介绍:
Toxicon has an open access mirror Toxicon: X, sharing the same aims and scope, editorial team, submission system and rigorous peer review. An introductory offer Toxicon: X - full waiver of the Open Access fee.
Toxicon''s "aims and scope" are to publish:
-articles containing the results of original research on problems related to toxins derived from animals, plants and microorganisms
-papers on novel findings related to the chemical, pharmacological, toxicological, and immunological properties of natural toxins
-molecular biological studies of toxins and other genes from poisonous and venomous organisms that advance understanding of the role or function of toxins
-clinical observations on poisoning and envenoming where a new therapeutic principle has been proposed or a decidedly superior clinical result has been obtained.
-material on the use of toxins as tools in studying biological processes and material on subjects related to venom and antivenom problems.
-articles on the translational application of toxins, for example as drugs and insecticides
-epidemiological studies on envenoming or poisoning, so long as they highlight a previously unrecognised medical problem or provide insight into the prevention or medical treatment of envenoming or poisoning. Retrospective surveys of hospital records, especially those lacking species identification, will not be considered for publication. Properly designed prospective community-based surveys are strongly encouraged.
-articles describing well-known activities of venoms, such as antibacterial, anticancer, and analgesic activities of arachnid venoms, without any attempt to define the mechanism of action or purify the active component, will not be considered for publication in Toxicon.
-review articles on problems related to toxinology.
To encourage the exchange of ideas, sections of the journal may be devoted to Short Communications, Letters to the Editor and activities of the affiliated societies.